Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,825 | 9 | 39.8% |
| Consulting Fee | $4,350 | 3 | 25.4% |
| Travel and Lodging | $3,807 | 16 | 22.2% |
| Food and Beverage | $1,824 | 30 | 10.6% |
| Education | $325.00 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $15,788 | 38 | $0 (2024) |
| Celgene Corporation | $522.43 | 8 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $194.16 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $127.58 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $119.84 | 1 | $0 (2024) |
| PFIZER INC. | $114.14 | 1 | $0 (2023) |
| ABBVIE INC. | $109.37 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $91.05 | 1 | $0 (2024) |
| Sandoz Inc. | $47.06 | 2 | $0 (2024) |
| Ardelyx, Inc. | $17.91 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,935 | 23 | Lilly USA, LLC ($8,510) |
| 2023 | $3,711 | 14 | Lilly USA, LLC ($3,118) |
| 2022 | $4,378 | 19 | Lilly USA, LLC ($4,160) |
| 2021 | $106.32 | 3 | Celgene Corporation ($59.21) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $114.79 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $119.84 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $91.05 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Immunology | ||||||
| 08/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Immunology | ||||||
| 08/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Immunology | ||||||
| 08/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Immunology | ||||||
| 07/12/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Immunology | ||||||
| 05/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $571.69 | General |
| 05/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $450.30 | General |
| 05/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $208.30 | General |
| 05/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $154.08 | General |
| 05/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $154.08 | General |
| 05/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $132.96 | General |
| 05/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $132.96 | General |
| 03/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Immunology | ||||||
| 02/15/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Immunology | ||||||
| 12/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $102.32 | General |
| Category: Neuroscience | ||||||
| 12/14/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 52 | $11,764 | $3,166 |
| 2022 | 2 | 58 | 64 | $15,424 | $3,964 |
| 2021 | 2 | 56 | 60 | $14,580 | $3,848 |
| 2020 | 2 | 32 | 34 | $8,236 | $1,757 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 40 | $9,520 | $2,639 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 12 | $2,244 | $527.34 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 44 | 48 | $11,424 | $2,890 | 25.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 14 | 16 | $4,000 | $1,074 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 35 | $8,330 | $2,226 | 26.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 25 | 25 | $6,250 | $1,622 | 25.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 22 | $5,236 | $1,052 | 20.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 12 | 12 | $3,000 | $705.06 | 23.5% |
About Erin Darguzas, APN
Erin Darguzas, APN is a Acute Care healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1801227954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erin Darguzas, APN has received a total of $17,131 in payments from pharmaceutical and medical device companies, with $8,935 received in 2024. These payments were reported across 59 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,825).
As a Medicare-enrolled provider, Darguzas has provided services to 195 Medicare beneficiaries, totaling 210 services with total Medicare billing of $12,735. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Chicago, IL
- Active Since 11/27/2013
- Last Updated 11/27/2013
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801227954
Products in Payments
- OMVOH (Drug) $6,706
- ZEPOSIA (Drug) $522.43
- STELARA (Biological) $194.16
- TREMFYA (Drug) $127.58
- TRULANCE (Drug) $119.84
- ENTYVIO (Biological) $91.05
- SKYRIZI (Biological) $75.05
- HYRIMOZ (Biological) $47.06
- HUMIRA (Biological) $34.32
- IBSRELA (Drug) $17.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Chicago
Gwen Cassidy, Apn, APN
Acute Care — Payments: $46,167
Ms. Tedra Gray, N.p, N.P
Acute Care — Payments: $42,525
Mrs. Katie Meador, Nurse Practitioner, NURSE PRACTITIONER
Acute Care — Payments: $15,088
Sarah Miyata, Np, NP
Acute Care — Payments: $11,047
Viktoriya Kagan, Aprn, Cnp, APRN, CNP
Acute Care — Payments: $7,096
Danielle Zielinski, Acnp, ACNP
Acute Care — Payments: $5,292